awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28282265-26C58D8B-620F-4634-B230-91D263BB1C31
Q28282265-26C58D8B-620F-4634-B230-91D263BB1C31
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28282265-26C58D8B-620F-4634-B230-91D263BB1C31
A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes
P2860
Q28282265-26C58D8B-620F-4634-B230-91D263BB1C31
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28282265-26C58D8B-620F-4634-B230-91D263BB1C31
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8358fb804e39baf58a9bac59b6440e57ab765ffc
P2860
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.